The 54th GST Council meeting, chaired by Finance Minister Nirmala Sitharaman, has approved a reduction in GST rates from 12% to 5% for three cancer drugs: trastuzumab deruxtecan, osimertinib, and… Continue Reading
Blogs
New Treatment Regimen for Multi-Drug-Resistant TB Approved
The Indian government has approved a new, shorter treatment for multi-drug-resistant tuberculosis (MDR-TB). This new regimen, called BPaLM, combines four drugs: Bedaquiline, Pretomanid, Linezolid, and optionally Moxifloxacin. It can cure… Continue Reading
Lenacapavir: New HIV Drug Could Cut Costs to $40 Annually. Slashing Current Costs by 1,000 Times
Lenacapavir Overview: Manufacturer: Gilead, a US pharmaceutical company. Type: Antiretroviral drug. Administration: Injected twice a year, simplifying treatment compared to daily pills. Effectiveness: 100% effective in preventing HIV infection in… Continue Reading
Victory for TB Patients in India
In a significant win for children suffering from tuberculosis (TB), more affordable versions of a crucial TB drug will soon be available in India. On July 5, the country’s patent… Continue Reading
Free medical treatment for citizens over 70 under Ayushman scheme
As per PTI report, President Droupadi Murmu announced that citizens aged above 70 will now get free medical treatment under the Ayushman Bharat health insurance scheme. She made this announcement… Continue Reading